Skip to main content
Terug
ORGJF logo

Organo Corporation

Datakwaliteit: 100%
Overbought
ORGJF
OTC Industrials Industrial - Pollution & Treatment Controls
€ 113,69
€ 0,00 (0,00%)
Marktkapitalisatie: 5,23B
Dagbereik
€ 95,51 € 113,69
52-Weeksbereik
€ 53,03 € 113,69
Volume
100
50D / 200D Gem.
€ 83,85 / € 60,73
Vorige Slotkoers
€ 113,69

Koershistorie

Financiële Trends

Sectorvergelijking

vs Industrials sector mediaan (894 peers)

Metriek Aandeel Sector Mediaan
P/E 0,2 14,4
P/B 0,0 1,9
ROE % 21,7 11,4
Net Margin % 14,8 6,5
Rev Growth 5Y % 12,9 8,4
D/E 0,2 0,6

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2029 € 0,00
€ 0,00 – € 0,00
 1,2 B 0
FY2028 € 4,57
€ 4,56 – € 4,61
 1,3 B 1
FY2027 € 4,28
€ 4,26 – € 4,31
 1,2 B 1

Belangrijkste Punten

Revenue grew 12,86% annually over 5 years — strong growth
Earnings grew 39,51% over the past year
ROE of 21,67% indicates high profitability
Debt/Equity of 0,19 — conservative balance sheet
Generating 18,41B in free cash flow
P/E of 0,22 — trading at a low valuation

Groei

Revenue Growth (5Y)
12,86%
Revenue (1Y)8,59%
Earnings (1Y)39,51%
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
21,67%
ROIC16,26%
Net Margin14,79%
Op. Margin19,06%

Veiligheid

Debt / Equity
0,19
Current Ratio2,55
Interest Coverage126,50

Waardering

P/E Ratio
0,22
P/B Ratio0,04
EV/EBITDA0,35
Dividend Yield0,02%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 8,59% Revenue Growth (3Y) 11,04%
Earnings Growth (1Y) 39,51% Earnings Growth (3Y) 43,49%
Revenue Growth (5Y) 12,86% Earnings Growth (5Y) 35,93%
Profitability
Revenue (TTM) 163,27B Net Income (TTM) 24,15B
ROE 21,67% ROA 12,42%
Gross Margin 33,80% Operating Margin 19,06%
Net Margin 14,79% Free Cash Flow (TTM) 18,41B
ROIC 16,26% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,19 Current Ratio 2,55
Interest Coverage 126,50 Dividend Yield 0,02%
Valuation
P/E Ratio 0,22 P/B Ratio 0,04
P/S Ratio 0,03 PEG Ratio 0,38
EV/EBITDA 0,35 Dividend Yield 0,02%
Market Cap 5,23B Enterprise Value 11,03B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 163,27B 150,36B 132,43B 112,07B 100,64B
Net Income 24,15B 17,31B 11,73B 9,21B 7,07B
EPS (Diluted) 525,36 376,92 255,77 200,67 154,18
Gross Profit 55,18B 43,84B 34,98B 28,51B 26,33B
Operating Income 31,12B 22,54B 15,21B 10,85B 9,58B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 194,40B 182,70B 164,85B 130,51B 115,01B
Total Liabilities 73,20B 80,56B 78,48B 54,50B 47,65B
Shareholders' Equity 120,95B 101,93B 86,17B 75,84B 67,21B
Total Debt 22,56B 36,47B 33,02B 15,63B 16,01B
Cash & Equivalents 16,75B 17,64B 15,56B 20,20B 12,80B
Current Assets 164,37B 153,47B 136,77B 102,86B 89,70B
Current Liabilities 64,40B 72,60B 68,74B 43,07B 40,75B

Strategiescores

This stock passed the criteria for 7 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Deep Value Investing (Seth Klarman)
#126 of 827
61
Growth Price/Sales Ratio Focus (Ken Fisher)
#561 of 618
10
Custom Contrarian Investing (David Dreman)
#543 of 670
10
Value Defensive Investing (Benjamin Graham)
#336 of 709
30
Value Value Investing (Warren Buffett)
#111 of 203
40
Custom Balanced Risk
#68 of 151
48
Custom Lower Risk
#61 of 140
47

Recente Activiteit

Ingestapt Deep Value Investing (Seth Klarman)
Mar 24, 2026
Ingestapt Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Ingestapt Contrarian Investing (David Dreman)
Mar 24, 2026
Ingestapt Defensive Investing (Benjamin Graham)
Mar 24, 2026
Ingestapt Value Investing (Warren Buffett)
Mar 24, 2026
Ingestapt Balanced Risk
Mar 24, 2026
Ingestapt Lower Risk
Mar 24, 2026